ANBT
REGN icon

American National Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

American National Bank & Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Sell
20
-55
-73% -$37.4K ﹤0.01% 466
2026
Q1 		$57.9K Sell
75
-1
-1% -$766 0.01% 345
2025
Q4 		$58.7K Hold
76
– – 0.01% 351
2025
Q3 		$42.7K Buy
76
+6
+9% +$3.39K ﹤0.01% 378
2025
Q2 		$36.8K Hold
70
– – ﹤0.01% 411
2025
Q1 		$44.4K Buy
+70
New +$48.1K ﹤0.01% 346
2023
Q3 		– Sell
-10
Closed -$7.18K – 635
2023
Q2 		$7.18K Hold
10
– – ﹤0.01% 436
2023
Q1 		$8.22K Hold
10
– – ﹤0.01% 412
2022
Q4 		$7K Sell
10
-3
-23% -$2.21K ﹤0.01% 408
2022
Q3 		$9K Sell
13
-28
-68% -$17.6K ﹤0.01% 376
2022
Q2 		$24K Buy
41
+31
+310% +$20.1K 0.01% 235
2022
Q1 		$7K Buy
+10
New +$6.33K ﹤0.01% 338
2021
Q2 		– Sell
-10
Closed -$5K – 312
2021
Q1 		$5K Buy
+10
New +$4.87K ﹤0.01% 232
2017
Q1 		– Sell
-4
Closed -$1K – 314
2016
Q4 		$1K Buy
+4
New +$1.52K ﹤0.01% 273

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

American National Bank & Trust's REGN Position: Q2 2026 in Review

American National Bank & Trust reduced its Regeneron Pharmaceuticals (REGN) stake by 73% in Q2 2026, selling an estimated $37.4K and leaving 20 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #466.

American National Bank & Trust first reported a position in REGN in Q4 2016 and has held it in 14 quarters since. The position peaked at $58.7K in Q4 2025. 404 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • American National Bank & Trust held 20 shares of Regeneron Pharmaceuticals worth $12.5K as of Q2 2026.
  • American National Bank & Trust sold 55 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $37.4K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of American National Bank & Trust's portfolio in Q2 2026, its #466 holding.
  • American National Bank & Trust first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 14 quarters since.
  • American National Bank & Trust's Regeneron Pharmaceuticals position peaked at $58.7K in Q4 2025.
  • 404 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.